IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.812
NA - Nord America 7.245
AS - Asia 5.713
SA - Sud America 913
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 4
Totale 27.777
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.957
US - Stati Uniti d'America 7.121
SG - Singapore 2.093
IE - Irlanda 1.563
CN - Cina 1.153
HK - Hong Kong 999
UA - Ucraina 793
BR - Brasile 762
GB - Regno Unito 658
VN - Vietnam 613
IT - Italia 536
DE - Germania 443
SE - Svezia 253
FI - Finlandia 219
TR - Turchia 192
KR - Corea 189
GR - Grecia 154
JP - Giappone 139
IN - India 123
FR - Francia 99
AR - Argentina 61
CA - Canada 55
BD - Bangladesh 51
MX - Messico 36
AT - Austria 32
EC - Ecuador 27
IQ - Iraq 27
NL - Olanda 23
BE - Belgio 21
ID - Indonesia 21
ZA - Sudafrica 17
MA - Marocco 16
CO - Colombia 15
UZ - Uzbekistan 14
VE - Venezuela 14
CL - Cile 13
PK - Pakistan 13
PL - Polonia 13
EU - Europa 12
ES - Italia 11
EG - Egitto 9
KE - Kenya 9
MY - Malesia 8
SA - Arabia Saudita 8
IL - Israele 7
IR - Iran 7
LT - Lituania 7
PE - Perù 7
TN - Tunisia 7
PA - Panama 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
ET - Etiopia 5
HN - Honduras 5
KZ - Kazakistan 5
PH - Filippine 5
SN - Senegal 5
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LB - Libano 4
NP - Nepal 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
NI - Nicaragua 3
OM - Oman 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
CY - Cipro 2
CZ - Repubblica Ceca 2
JO - Giordania 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
LI - Liechtenstein 1
Totale 27.763
Salva come PNG Salva come JPEG
Città #
Moscow 3.102
Dublin 1.562
Jacksonville 1.202
Santa Clara 992
Hong Kong 990
Singapore 846
Chandler 707
San Jose 633
Ashburn 294
Princeton 243
New York 197
Roxbury 195
Seoul 186
Ho Chi Minh City 183
Hanoi 144
Ann Arbor 143
Cambridge 142
Beijing 140
Woodbridge 121
Dallas 120
Boardman 115
Bremen 108
Wilmington 108
Hefei 105
Medford 105
The Dalles 89
Bengaluru 61
Jinan 56
São Paulo 56
San Mateo 55
Des Moines 54
Munich 52
Mountain View 50
Orem 50
Nanjing 48
Naples 47
Da Nang 46
Düsseldorf 45
Los Angeles 43
Shenyang 42
Nuremberg 41
Memphis 33
Haiphong 28
Norwalk 28
Napoli 27
Caserta 25
Chennai 24
Belo Horizonte 21
Bologna 21
Brussels 21
Washington 21
Milan 20
Changsha 19
Helsinki 19
Rio de Janeiro 19
Zhengzhou 19
Brasília 18
Guangzhou 18
Houston 18
Lanzhou 17
Tianjin 17
Ningbo 16
Rome 16
Tokyo 16
Toronto 16
Atlanta 15
Biên Hòa 15
Campinas 15
Amsterdam 14
Marano Di Napoli 14
Frankfurt am Main 13
Haikou 13
Hangzhou 13
Taizhou 13
Baghdad 12
Salvador 12
Tashkent 12
Vienna 12
Guadalupe 11
Hebei 11
Hải Dương 11
Istanbul 11
London 11
Nanchang 11
Porto Alegre 11
San Francisco 11
Seattle 11
Thái Bình 11
Thái Nguyên 11
Auburn Hills 10
Bari 10
Brooklyn 10
Council Bluffs 10
Guayaquil 10
Warsaw 10
Casablanca 9
Montreal 9
Ninh Bình 9
Ottawa 9
Quito 9
Totale 14.414
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 206
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 191
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 181
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 176
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 170
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 170
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 165
Chronic HCV infection and neurological and psychiatric disorders: an overview. 164
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 162
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 161
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 158
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 154
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 152
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 152
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 151
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 150
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 149
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 149
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 149
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 148
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 148
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 148
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 147
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 146
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 142
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 140
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19 139
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 138
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 138
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 138
Virological patterns of HCV patients with failure to interferon-free regimens. 136
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 135
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 135
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 134
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 134
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 134
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 134
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 134
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 133
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 132
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 132
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 132
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 131
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 130
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 130
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 130
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 129
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 128
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 128
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 126
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 126
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 126
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 126
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 126
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 126
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 125
HCV-related steatosis and risk of atherosclerosis 125
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 123
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 123
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 122
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 122
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 122
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 121
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 121
Viral Hepatitis C 120
Inotropes administration in patients with acute infective endocarditis and indication for urgent cardiac surgery 119
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 119
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 119
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 119
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 118
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 118
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 118
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 118
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 117
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 117
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 116
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 116
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 116
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 116
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 115
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 115
Occult HBV infection in the oncohematological setting. 115
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 115
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 115
Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review 115
Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future 114
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 114
Efficacia del trattamento con interferone ricombinante e linfoblastoide in pazienti con epatite cronica da HCV. 114
Drugs and liver injury: a not to be overlooked binomial in COVID-19 114
Clinical correlates of circulating small dense low-density lipoproteins in acute infective endocarditis 113
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 113
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 113
Treatment of chronic HBV infection in developing countries. 113
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 113
Management of carbapenem resistant Enterobacteriaceae infections 113
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 112
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici. Nostra esperienza negli ultimi 4 anni. 112
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 112
Totale 13.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/20221.445 58 13 4 14 482 19 26 44 63 149 109 464
2022/20232.898 261 48 31 222 333 222 10 165 1.467 25 56 58
2023/20241.177 93 28 41 72 420 181 34 35 6 13 88 166
2024/20253.722 8 48 32 84 589 594 560 311 443 578 322 153
2025/202614.474 461 570 677 744 1.137 8.413 737 550 517 300 252 116
Totale 28.223